Scarica l'app Stockscreener
0.17
9.09%
-0.017
Dopo l'orario di chiusura:
.17
Virios Therapeutics Inc Borsa (VIRI) Ultime notizie
Virios Therapeutics (NASDAQ:VIRI) Stock Quotes, Forecast and News Summary - Benzinga
The Psychology of Virios Therapeutics Inc Inc. (VIRI) Price Performance: Understanding Market Sentiment - The InvestChronicle
It would be worthwhile to take a closer look at Virios Therapeutics Inc (VIRI) - US Post News
Vicor Corporation Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky for More InformationVICR - AccessWire
MONDAY INVESTOR DEADLINE: Vicor Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitVICR - AccessWire
Virios Therapeutics Inc (VIRI) Stock: From Low to High in 52 Weeks - The InvestChronicle
Virios Therapeutics Inc (VIRI)’s Market Momentum: Closing Strong at 0.19, Up 7.78 - The Dwinnex
Take off with Virios Therapeutics Inc (VIRI): Get ready for trading - SETE News
Stock Performance Spotlight: Virios Therapeutics Inc (VIRI) Ends the Day at 0.21, Down by -3.94 - The Dwinnex
Virios Therapeutics Inc (VIRI) did well last session? - US Post News
Reviewing Virios Therapeutics (NASDAQ:VIRI) & Xencor (NASDAQ:XNCR) - Defense World
Virios Therapeutics Inc (VIRI) expanding its growth trajectory ahead - SETE News
VIRI’s Stock Market Pendulum: Swinging Between Gains and Losses - The InvestChronicle
Analyzing VIRI’s price-to-book ratio for the last quarter - US Post News
VIRI: Enrollment Complete in Phase 2a Long COVID Trial; Results Expected in October 2024… - MSN
VIRI: Enrollment Complete in Phase 2a Long COVID Trial; Results Expected in October 2024… - Yahoo Finance
HC Wainwright Cuts Virios Therapeutics (NASDAQ:VIRI) Price Target to $0.20 - Defense World
Virios Therapeutics Announces Second Quarter 2024 Financial Results - Marketscreener.com
Virios Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 - Marketscreener.com
Virios Therapeutics Announces Second Quarter 2024 Financial Results - GlobeNewswire
Virios Therapeutics Announces Second Quarter 2024 Financial Results - StockTitan
Virios Therapeutics (VIRI) to Release Earnings on Thursday - Defense World
Virios Therapeutics Inc (VIRI)’s Market Momentum: Closing Strong at 0.19, Down -8.25 - The Dwinnex
Virios Therapeutics to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024 - ForexTV.com
VIRIVirios Therapeutics, Inc. Latest Stock News & Market Updates - StockTitan
Virios Therapeutics to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024 - WDRB
Virios Therapeutics to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024 - GlobeNewswire
Taking on analysts’ expectations and winning: Virios Therapeutics Inc (VIRI) - SETE News
Virios Therapeutics Inc (VIRI) deserves closer scrutiny - US Post News
Ratios Reveal: Breaking Down Virios Therapeutics Inc (VIRI)’s Financial Health - The Dwinnex
Virios Therapeutics Inc (VIRI) Stock: The Story of a 52-Week Stock Range - The InvestChronicle
Virios Therapeutics Announces Completion of Enrollment in - GlobeNewswire
Virios Therapeutics Announces Completion of Enrollment in IMC-2 Phase 2 Long-COVID Study Being Conducted by Bateman Horne Center - StockTitan
Prepare Yourself for Liftoff: Virios Therapeutics Inc (VIRI) - SETE News
Does Virios Therapeutics Inc (NASDAQ: VIRI) Still Need To Convince Analysts? - Stocks Register
Upward Trajectory: Virios Therapeutics Inc (VIRI) Posts a Slidee, Closing at 0.25 - The Dwinnex
Why Tellurian Shares Are Trading Higher By Around 65%; Here Are 20 Stocks Moving Premarket - Benzinga
Why Chuy's Holdings Shares Are Trading Higher By 47%; Here Are 20 Stocks Moving Premarket - Benzinga
How does Virios Therapeutics Inc (VIRI) change from a tortoise to a hare? - SETE News
In the Green: Virios Therapeutics Inc (VIRI) Closes at 0.24, Up/Down -2.36 from Previous Day - The Dwinnex
Virios Therapeutics Inc (VIRI) is a good investment, but the stock may be overvalued - US Post News
Virios Therapeutics, Inc. (NASDAQ:VIRI) Sees Large Decline in Short Interest - Defense World
Gaining Ground: Virios Therapeutics Inc (VIRI) Closes Lower at 0.26, Down -1.53 - The Dwinnex
The Virios Therapeutics Inc (VIRI) had a good session last reading, didn’t it? - US Post News
VIRI’s Stock Market Expedition: Traversing Gains and Losses in 2023 - The InvestChronicle
Zika Virus Therapeutics Market size is set to grow by USD 4.17 billion from 2024-2028, Availability of serology kit for qualitative diagnosis of zika virus infection to boost the market growth, Technavio - Yahoo Finance
Virios Therapeutics Inc (VIRI) Stock: A Comprehensive 52-Week Review - The InvestChronicle
How does Virios Therapeutics Inc (VIRI) change from a tortoise to a hare? – Sete News - SETE News
Virios Therapeutics Inc (VIRI) is an excellent investment, but the stock is overvalued/undervalued right now – US Post ... - US Post News
Viridien: Information on the total number of voting rights and shares - GlobeNewswire Inc.
Virios Therapeutics, Inc. (NASDAQ:VIRI) Short Interest Up 70.1% in June - Defense World
Viridien : Lancement du regroupement des actions Viridien - GlobeNewswire Inc.
Virios Therapeutics Inc (VIRI) Stock: A Year of Decreases and Increases - The InvestChronicle
A Look at Virios Therapeutics Inc (VIRI) Shares in the Recent Past Indicates Growth – Sete News - SETE News
How did Virios Therapeutics Inc (VIRI) fare last session? – US Post News - US Post News
Deeper Dive: Understanding Virios Therapeutics Inc (VIRI) Through its Various Ratios – DWinneX - The Dwinnex
Virios Therapeutics ratifies auditor, elects directors By Investing.com - Investing.com
Virios Therapeutics ratifies auditor, elects directors - Investing.com India
Adversity is less terrifying than hope: Virios Therapeutics Inc (VIRI) – Sete News - SETE News
Virios Therapeutics (NASDAQ:VIRI) Receives New Coverage from Analysts at Maxim Group - Defense World
Virios Therapeutics Inc (VIRI) Stock: Navigating Market Highs and Lows in 52 Weeks - The InvestChronicle
Did Virios Therapeutics Inc (VIRI) perform well in the last session? – US Post News - US Post News
Virios Therapeutics Inc (VIRI) is a good investment, but the stock may be overvalued – US Post News - US Post News
Viridien conclut la vente d’un système de surveillance et d’alerte des navires, Marlin, auprès d’ExxonMobil Guyana Ltd - GlobeNewswire Inc.
Virios Therapeutics receives Nasdaq compliance extension By Investing.com - Investing.com
Virios Therapeutics receives Nasdaq compliance extension - Investing.com India
0.05%
4.86%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):